City noise worsens fibromyalgia pain, new research reveals—urban sounds trigger sharper symptoms than silence or...
Discover how spinal muscular atrophy treatment has evolved with disease-modifying therapies and early intervention for...
Researchers discover new multiple sclerosis treatment using small molecule CN045 to promote remyelination activity.
FDA approves tau PET imaging agent Tauklarify for Alzheimer’s disease, backed by two large studies...
Blood biomarkers are revolutionizing early Alzheimer detection, with a new P‑tau217 blood test matching PET...
Spinal muscular atrophy treatment breakthroughs extend lives, but healthcare systems struggle to adapt to new...
Takeda's oveporexton approved for narcolepsy type 1 treatment as first medicine to target orexin signaling...
Lennox-Gastaut syndrome presents complex care challenges. Learn about treatment advancements and how to plan for...
Thymidine kinase deficiency approval brings new hope as drugs doxecitine and doxribtimine receive regulatory clearance,...
The FDA will review tau PET imaging agent MK-6240 on August 13, seeking better Alzheimer...